Maria Karlgren

Classification of Inhibitors of Hepatic Organic Anion Transporting Polypeptides (OATPs): Influence of Protein Expression on Drug–Drug Interactions

Maria Karlgren, Anna Vildhede, Ulf Norinder et al. · Journal of Medicinal Chemistry · 2012 · 365 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +14

Tumor-specific expression of the novel cytochrome P450 enzyme, CYP2W1

Maria Karlgren, Alvin Gomez, Katarina Stark et al. · Biochemical and Biophysical Research Communications · 2006 · 119 citations

Medicine, Oncology, Pharmacology +14

In Vitro and In Silico Strategies to Identify OATP1B1 Inhibitors and Predict Clinical Drug–Drug Interactions

Maria Karlgren, Gustav Ahlin, Christel A. S. Bergström et al. · Pharmaceutical Research · 2011 · 119 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Hepatic Uptake of Atorvastatin: Influence of Variability in Transporter Expression on Uptake Clearance and Drug-Drug Interactions

Anna Vildhede, Maria Karlgren, Elin Svedberg et al. · Drug Metabolism and Disposition · 2014 · 110 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Comparative Proteomic Analysis of Human Liver Tissue and Isolated Hepatocytes with a Focus on Proteins Determining Drug Exposure

Anna Vildhede, Jacek R. Wiśniewski, Agneta Norén et al. · Journal of Proteome Research · 2015 · 106 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17